Erythromycin ethylsuccinate (Compound)

Synonyms:erythromycin ethylsuccinate, 1264-62-6, Pediamycin, EryPed, Wyamycin E, Erythromycin, 2'-(ethyl butanedioate), Erythromycin ethyl succinate, C43H75NO16, UNII-1014KSJ86F, Erythroped, MLS001074901, CHEBI:31555, Erythrocin ethyl succinate, 1014KSJ86F, E-Mycin E, SMR000058868, Erythromycin 2'-(ethyl succinate), ERY-PED, PEDIAMYCIN 400, EES Granules, E.E.S, Erythromycin, ethyl succinate, EES (Antiobiotic), HSDB 3075, Erythromycin, mono(ethyl succinate), EINECS 215-033-8, Erythromycin 2'-(ethyl butanedioate), BRN 0077638, Wyamycin, E.E.S., Erythromycin, mono(ethyl succinate) (ester), NCGC00183038-01, 41342-53-4, E-Mycin-E, E.E.S 200, E.E.S 400, Eryped (TN), Erythrocin W (TN), Erythromycin ethylsuccinate [USP:JAN], Succinic acid, monoethyl ester, monoester with erythromycin, Spectrum_001046, Spectrum2_000983, Spectrum3_000419, Spectrum4_000536, Spectrum5_000668, erythromycin-ethylsuccinate, DSSTox_CID_2993, Erythromycin-ethyl succinate, DSSTox_RID_76821, DSSTox_GSID_22993, Erythromycin A Ethylsuccinate, SCHEMBL18259, BSPBio_001978, KBioGR_001171, KBioSS_001526, 4-18-00-07416 (Beilstein Handbook Reference), MLS000028651, MLS001076672, succinicacid,monoethylester,monoesterwitherythromycin, DivK1c_000764, SPECTRUM1500279, SPBio_001045, cid_443953, CHEMBL1200688, DTXSID4022993, BDBM96262, E.E.S. (TN), HMS502G06, KBio1_000764, KBio2_001526, KBio2_004094, KBio2_006662, KBio3_001198, NINDS_000764, Sterile erythromycin ethylsuccinate, HMS1923I21, HMS2091D03, Pharmakon1600-01500279, ERITHROMYCIN ETHYL SUCCINATE, HY-B0957, 2'-(Ethyl butanedioate)erythromycin, Tox21_113497, CCG-40201, LMPK05000001, MFCD00084692, NSC756758, s4060, AKOS008145410, ZINC169356230, CS-4434, MCULE-3725545409, NSC 756758, NSC-756758, Erythromycin ethylsuccinate (JP17/USP), IDI1_000764, NCGC00021382-03, CAS-1264-62-6, SBI-0051367.P003, D01361, AB00051980_11

Pubchem:PUBCHEM:443953

Id:443953

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Erythromycin ethylsuccinate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Erythromycin ethylsuccinate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Erythromycin ethylsuccinate.

Results found

Linked to

	Label	Description
	BRD-K51677086-001-13-8 Substance (Entity type)	A Substance
	DCSTRUCT ID 01051 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01051; PubChem_CID:443953, FILE=drugcentral_drug_01051.json)
	Erythromycin ethylsuccinate indication Abdominal Infection Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Infection of skin and/or subcutaneous tissue Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Hepatic Coma Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Meningitis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Infection of bone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Pneumonia, Bacterial Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Arthropathy associated with infection Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Erythromycin ethylsuccinate indication Urinary tract infection Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG